Genetics of caffeine consumption and responses to caffeine
Open accessThe DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
RationaleCaffeine is widely consumed in foods and beverages and is also used for a variety of medical purposes. Despite its widespread use, relatively little is understood regarding how genetics affects consumption, acute response, or the long-term effects of caffeine.ObjectiveThis paper reviews the literature on the genetics of caffeine from the following: (1) twin studies comparing heritability of consumption and of caffeine-related traits, including withdrawal symptoms, caffeine-induced insomnia, and anxiety, (2) association studies linking genetic polymorphisms of metabolic enzymes and target receptors to variations in caffeine response, and (3) case-control and prospective studies examining relationship between polymorphisms associated with variations in caffeine response to risks of Parkinson’s and cardiovascular diseases in habitual caffeine consumers.ResultsTwin studies find the heritability of caffeine-related traits to range between 0.36 and 0.58. Analysis of polysubstance use shows that predisposition to caffeine use is highly specific to caffeine itself and shares little common disposition to use of other substances. Genome association studies link variations in adenosine and dopamine receptors to caffeine-induced anxiety and sleep disturbances. Polymorphism in the metabolic enzyme cytochrome P-450 is associated with risk of myocardial infarction in caffeine users.ConclusionModeling based on twin studies reveals that genetics plays a role in individual variability in caffeine consumption and in the direct effects of caffeine. Both pharmacodynamic and pharmacokinetic polymorphisms have been linked to variation in response to caffeine. These studies may help guide future research in the role of genetics in modulating the acute and chronic effects of caffeine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methodology for Genetic Studies of Twins and Families
Neale, M. C., & Cardon, L. R. (1992) · doi:10.1007/978-94-015-8018-2 · Cited by 4,005
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 5×
“Activation of the Gi- or Go-coupled A1 causes inhibition of adenyl cyclase and Ca channels, whereas activation of Gs-coupled A2A causes activation of adenyl cyclase and voltage-sensitive Ca channels (Fredholm et al. 1999).”
InfluentialThe Role and Regulation of Adenosine in the Central Nervous System
Dunwiddie, T. V., & Masino, S. A. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.31 · Cited by 1,632
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073679 · Cited by 948
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Sachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00898.x · Cited by 751
Food sources and intakes of caffeine in the diets of persons in the United States
Frary, C. D., Johnson, R. K., & Wang, M. Q. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.10.027 · Cited by 681
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677 · cited 3×
“Case-control studies have noted an inverse correlation between coffee drinking and Parkinson’s disease (Ascherio et al. 2001; Ross et al. 2000), though this result has not always been replicated (Checkoway et al.”
Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90173-9 · Cited by 650
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine
Huang, Z.-L., Qu, W.-M., Eguchi, N., Chen, J.-F., Schwarzschild, M. A., Fredholm, B. B., Urade, Y., & Hayaishi, O. (2005) · Nature Neuroscience · doi:10.1038/nn1491 · Cited by 640 · cited 2×
“Mice lacking functional A 2A receptors do not show increased wakefulness in response to caffeine administration, indicating that the A 2A receptor mediates the arousal response (Huang et al. 2005).”
Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease
Chen, J.-F., Xu, K., Petzer, J. P., Staal, R., Xu, Y.-H., Beilstein, M., Sonsalla, P. K., Castagnoli, K., Castagnoli, N., & Schwarzschild, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0001.2001 · Cited by 606
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 590
Lieberman, H., Tharion, W., Shukitt-Hale, B., Speckman, K., & Tulley, R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1217-9 · Cited by 576
Caffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3269-3 · Cited by 538
Tolerance to the humoral and hemodynamic effects of caffeine in man.
Robertson, D., Wade, D., Workman, R., Woosley, R. L., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110124 · Cited by 501 · cited 1×
“(Evans and Griffiths 1992; Robertson et al. 1981), such that the effects of caffeine in habitual consumers are quite different from caffeine-naïve individuals.”
Coffee, CYP1A2 genotype, and risk of myocardial infarction
Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H. (2006) · JAMA · doi:10.1001/jama.295.10.1135 · Cited by 490 · cited 3×
“…does not appear to differ between the genotypes (Cornelis et al. 2007) Risk of nonfatal myocardial infarction higher for subjects with C/C genotype (Cornelis et al. 2006) No association found for risk of Parkinson's disease (Facheris et al. 2008) rs35694136 No association found for risk of…”
InfluentialKendler, K. S., Schmitt, E., Aggen, S. H., & Prescott, C. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.6.674 · Cited by 488
Stress Cardiomyopathy After Intravenous Administration of Catecholamines and Beta-Receptor Agonists
Abraham, J., Mudd, J. O., Kapur, N., Klein, K., Champion, H. C., & Wittstein, I. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.020 · Cited by 454
Daly, J. W., Butts-Lamb, P., & Padgett, W. (1983) · Cellular and Molecular Neurobiology · doi:10.1007/bf00734999 · Cited by 442
Symptoms of Anxiety and Symptoms of Depression: Same Genes, Different Environments?
Kendler, K. S. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800170073010 · Cited by 441
An Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440 · cited 2×
“The psychomotor stimulant effects of caffeine are due to antagonism of adenosine's inhibitory actions on the striatal D 2 transmission (Ferre 2008).”
Increased Anxiogenic Effects of Caffeine in Panic Disorders
Charney, D. S. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260027003 · Cited by 428
Clinical Pharmacology of Caffeine
Benowitz, N. L. (1990) · Annual Review of Medicine · doi:10.1146/annurev.me.41.020190.001425 · Cited by 420
The effects of low doses of caffeine on human performance and mood
Lieberman, H. R., Wurtman, R. J., Emde, G. G., Roberts, C., & Coviella, I. L. G. (1987) · Psychopharmacology · doi:10.1007/bf00210835 · Cited by 413
Noordzij, M., Uiterwaal, C. S., Arends, L. R., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000166828.94699.1d · Cited by 376 · cited 1×
“Some epidemiological studies find that regular coffee intake slightly increases blood pressure (Jee et al. 1999; Noordzij et al. 2005), while others find no difference.”
Checkoway, H., Powers, K., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., & Swanson, P. D. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.8.732 · Cited by 369
Kendler, K. S., Myers, J., & Prescott, C. A. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1313 · Cited by 369
Does caffeine intake protect from Alzheimer's disease?
Maia, L., & De Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357
Haskell, C. F., Kennedy, D. O., Wesnes, K. A., & Scholey, A. B. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2104-3 · Cited by 356
LeWitt, P. A., Guttman, M., Tetrud, J. W., Tuite, P. J., Mori, A., Chaikin, P., Sussman, N. M., & 6002‐US‐005 Study Group (2008) · Annals of Neurology · doi:10.1002/ana.21315 · Cited by 356
Coffee, caffeine and blood pressure: a critical review
Nurminen, M.-L., Niittynen, L., Korpela, R., & Vapaatalo, H. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600899 · Cited by 351
Beta EEG activity and insomnia
Perlis, M. L., Merica, H., Smith, M. T., & Giles, D. E. (2001) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0151 · Cited by 346
Spectral characteristics of sleep EEG in chronic insomnia
Merica, H., Blois, R., & Gaillard, J. ‐. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00189.x · Cited by 345
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334 · cited 5×
“2007) and the T allele to anxiety in Caucasian subjects (Alsene et al. 2003).”
InfluentialAddiction and its reward process through polymorphisms of the D2dopamine receptor gene: a review
Noble, E. P. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00208-x · Cited by 314
Rétey, J. V., Adam, M., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H.-P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100102 · Cited by 278 · cited 6×
“In human subjects, the rs5751876 polymorphism in the A 2A receptor is associated with sleep impairment and increased electroencephalogram (EEG) beta band activity after caffeine administration (Retey et al. 2007).”
InfluentialJee, S. H., He, J., Whelton, P. K., Suh, I., & Klag, M. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.647 · Cited by 276 · cited 1×
“Some epidemiological studies find that regular coffee intake slightly increases blood pressure (Jee et al. 1999; Noordzij et al. 2005), while others find no difference.”
Andersen, L. F., Jacobs, D. R., Carlsen, M. H., & Blomhoff, R. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.5.1039 · Cited by 262 · cited 2×
“Despite its deleterious effects in acute settings, several large-scale studies have found that habitual heavy use is protective against cardiovascular disease (Andersen et al. 2006).”
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities
Kalow, W., & Tang, B.-K. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.176 · Cited by 261
Gunes, A., & Dahl, M.-L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.625 · Cited by 256
Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J., & de Wit, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.17 · Cited by 251
Self-citationFuxe, K., Agnati, L. F., Jacobsen, K., Hillion, J., Canals, M., Torvinen, M., Tinner-Staines, B., Staines, W., Rosin, D., Terasmaa, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000095206.44418.5c · Cited by 248
Rasmussen (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00008 · Cited by 241 · cited 2×
“725 (Rasmussen et al. 2002).”
InfluentialCaffeine — an atypical drug of dependence
Daly, J. W., & Fredholm, B. B. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00077-5 · Cited by 240
Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption
Cornelis, M. C., El-Sohemy, A., & Campos, H. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.240 · Cited by 230
The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans
Garrett, B. E., & Griffiths, R. R. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00435-2 · Cited by 224
Arnaud, M. J. (1987) · Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques · doi:10.1007/978-3-0348-9289-6_9 · Cited by 219
Twin Studies of Psychiatric Illness: Current Status and Future Directions
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820230075007 · Cited by 214
Monopoli, A., Lozza, G., Forlani, A., Mattavelli, A., & Ongini, E. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00034 · Cited by 200
Martinez-Mir, M. I., Probst, A., & Palacios, J. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90038-p · Cited by 198
Caffeine and the dopaminergic system
Cauli, O., & Morelli, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00001 · Cited by 195
Swanson, J. A., Lee, J. W., & Hopp, J. W. (1994) · Addictive Behaviors · doi:10.1016/0306-4603(94)90027-2 · Cited by 178
Garattini, S. K. (1993) · Raven Press eBooks · Cited by 173
Grosso, L. M., & Bracken, M. B. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.12.011 · Cited by 173
Acute and long-term cardiovascular effects of coffee: Implications for coronary heart disease
Riksen, N. P., Rongen, G. A., & Smits, P. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.006 · Cited by 168
Shi, D., Nikodijević, O., Jacobson, K. A., & Daly, J. W. (1993) · Cellular and Molecular Neurobiology · doi:10.1007/bf00733753 · Cited by 163
Deckert, J., Nöthen, M. M., Franke, P., Delmo, C., Fritze, J., Knapp, M., Maier, W., Beckmann, H., & Propping, P. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000345 · Cited by 162
Effect of Coffee on Endothelial Function in Healthy Subjects: The Role of Caffeine
PAPAMICHAEL, C. M., AZNAOURIDIS, K. A., KARATZIS, E. N., KARATZI, K. N., STAMATELOPOULOS, K. S., VAMVAKOU, G., LEKAKIS, J. P., & MAVRIKAKIS, M. E. (2005) · Clinical Science · doi:10.1042/cs20040358 · Cited by 161
Lelo, A., Birkett, D., Robson, R., & Miners, J. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb05246.x · Cited by 161
Heavy consumption of cigarettes, alcohol and coffee in male twins.
Swan, G. E., Carmelli, D., & Cardon, L. R. (1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.182 · Cited by 158
Caffeine tolerance and choice in humans
Evans, S. M., & Griffiths, R. R. (1992) · Psychopharmacology · doi:10.1007/bf02245285 · Cited by 157
Hypertension risk status and effect of caffeine on blood pressure
Hartley, T. R., Sung, B. H., Pincomb, G. A., Whitsett, T. L., Wilson, M. F., & Lovallo, W. R. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.137 · Cited by 156
Chronic caffeine consumption increases the number of brain adenosine receptors
Boulenger, J., Patel, J. B., Post, R. M., Parma, A. M., & Marangos, P. J. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90119-4 · Cited by 150
Coffee consumption and risk of coronary heart disease: a meta‐analysis
Sofi, F., Conti, A. A., Gori, A. M., Eliana Luisi, M. L., Casini, A., Abbate, R., & Gensini, G. F. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.07.013 · Cited by 148
Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder
Hamilton, S. P., Slager, S. L., Baisre, A., Heiman, G. A., Klein, D. F., Hodge, S. E., Weissman, M. M., Fyer, A. J., & Knowles, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300311 · Cited by 147
Lane, J. D., Adcock, R. A., Williams, R. B., & Kuhn, C. M. (1990) · Psychosomatic Medicine · doi:10.1097/00006842-199005000-00006 · Cited by 145 · cited 1×
“Caffeine may represent a chemical stress to the body due to its ability to potentiate catecholamine release (Lane et al. 1990).”
Does coffee drinking increase the risk of coronary heart disease? Results from a meta‐analysis
Kawachi, I., Colditz, G. A., & Stone, C. B. (1994) · Heart · doi:10.1136/hrt.72.3.269 · Cited by 144 · cited 1×
“Whether caffeine is implicated in cardiovascular diseases is still being debated (Kawachi et al. 1994; Riksen et al. 2009; Sofi et al. 2007).”
Swan, G. E., Carmelli, D., & Cardon, L. R. (1996) · Journal of Substance Abuse · doi:10.1016/s0899-3289(96)90055-3 · Cited by 143
Caffeine as an analgesic adjuvant in tension headache
Migliardi, J. R., Armellino, J. J., Friedman, M., Gillings, D. B., & Beaver, W. T. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.179 · Cited by 141
Effects of chronic caffeine on brain adenosine receptors: Regional and ontogenetic studies
Marangos, P. J., Boulenger, J., & Patel, J. B. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90207-8 · Cited by 140
Hettema, J. M., Corey, L. A., & Kendler, K. S. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00053-8 · Cited by 135
Adenosine A2aReceptor‐Mediated Modulation of Striatal [3H]GABA and [3H]Acetylcholine Release
Kirk, I. P., & Richardson, P. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62030960.x · Cited by 134
Carter, A. J., O'Connor, W. T., Carter, M. J., & Ungerstedt, U. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09521-7 · Cited by 132
Reinforcing effects of caffeine in humans.
Griffiths, R. R., & Woodson, P. P. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21004-7 · Cited by 127
Dietary Patterns and Heritability of Food Choice in a UK Female Twin Cohort
Teucher, B., Skinner, J. S., Skidmore, P. M. L., Cassidy, A., Fairweather‐Tait, S. J., Hooper, L., Roe, M. A., Foxall, R., Oyston, S. L., Cherkas, L. F., et al. (2007) · Twin Research and Human Genetics · doi:10.1375/twin.10.5.734 · Cited by 126
The use of caffeine as a metabolic probe for human drug metabolizing enzymes
Miners, J. O., & Birkett, D. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)02014-4 · Cited by 125
Caffeine Intake, Tolerance, and Withdrawal in Women: A Population-Based Twin Study
Kendler, K. S., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.223 · Cited by 124
Kietzmann, M. (1994) · Toxicon · doi:10.1016/0041-0101(94)90091-4 · Cited by 117
Heritability and Genetic Covariation of Sensitivity to PROP, SOA, Quinine HCl, and Caffeine
Hansen, J. L. (2006) · Chemical Senses · doi:10.1093/chemse/bjj044 · Cited by 111
Anxiogenic Effects of Caffeine in Patients With Anxiety Disorders
Bruce, M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110031004 · Cited by 108
Blood Pressure Response to Caffeine Shows Incomplete Tolerance After Short-Term Regular Consumption
Lovallo, W. R., Wilson, M. F., Vincent, A. S., Sung, B. H., McKey, B. S., & Whitsett, T. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000120965.63962.93 · Cited by 105
Marchi, M., Raiteri, L., Risso, F., Vallarino, A., Bonfanti, A., Monopoli, A., Ongini, E., & Raiteri, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704712 · Cited by 96 · cited 2×
“They are located on presynaptic terminals and mediate inhibitory effects of adenosine on the release of other neurotransmitters, including glutamate (Marchi et al. 2002), acetylcholine (Kurokawa et al.”
Marchi, M., Raiteri, L., Risso, F., Vallarino, A., Bonfanti, A., Monopoli, A., Ongini, E., & Raiteri, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704857 · Cited by 91
Zahniser, N. R., Simosky, J. K., Mayfield, R. D., Negri, C. A., Hanania, T., Larson, G. A., Kelly, M. A., Grandy, D. K., Rubinstein, M., Low, M. J., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-05949.2000 · Cited by 91
Heritability of Substance Use in the NAS-NRC Twin Registry
Carmelli, D., Swan, G. E., Robinette, D., & Fabsitz, R. R. (1990) · Acta geneticae medicae et gemellologiae · doi:10.1017/s0001566000005602 · Cited by 90
COFFEE USE PRIOR TO MYOCARDIAL INFARCTION RESTUDIED: HEAVIER INTAKE MAY INCREASE THE RISK
KLATSKY, A. L., FRIEDMAN, G. D., & ARMSTRONG, M. A. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115684 · Cited by 89 · cited 1×
“Long-term use of caffeine has been associated with an increased risk of cardiovascular diseases (Hartley et al. 2000; Klatsky et al. 1990) but a decreased risk in neurodegenerative disorders (Ascherio et al.”
Kashuba, A. D. M., Bertino, J., KEARNS, G., Leeder, J. S., James, A. W., Gotschall, R. R., & Nafziger, A. N. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90105-9 · Cited by 86
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
Dhaenens, C., Burnouf, S., Simonin, C., Brussel, E. V., Duhamel, A., Defebvre, L., Duru, C., Vuillaume, I., Cazeneuve, C., Charles, P., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.009 · Cited by 82
Panic disorder and social anxiety disorder subtypes in a caffeine challenge test
Nardi, A. E., Lopes, F. L., Freire, R. C. R., Veras, A. B., Nascimento, I., Valença, A. M., Neto, V. L. D. M., Soares‐Filho, G. L., King, A. L. S., Araújo, D. M. R., et al. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.023 · Cited by 81
Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma
Obase, Y., Shimoda, T., Kawano, T., Saeki, S., Tomari, S., Mitsuta, K., Matsuse, H., Kinoshita, M., & Kohno, S. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00013-4 · Cited by 81
Anxiogenic effects of caffeine on panic and depressed patients
Lee, M. A., Flegel, P., Greden, J. F., & Cameron, O. G. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.632 · Cited by 75
LOW‐DOSE CAFFEINE DISCRIMINATION AND SELF‐REPORTED MOOD EFFECTS IN NORMAL VOLUNTEERS
Silverman, K., & Griffiths, R. R. (1992) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1992.57-91 · Cited by 74
The cardiovascular effects of regular and decaffeinated coffee.
Smits, P., Thien, T. A., & Laar, A. V. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02729.x · Cited by 72
Popoli, P., Blum, D. L., Domenici, M. R., Burnouf, S., & Chern, Y. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480117 · Cited by 61
Association study of A2a adenosine receptor genetic polymorphism in panic disorder
Lam, P., Hong, C., & Tsai, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.012 · Cited by 60
Anxiety and caffeine consumption in people with anxiety disorders
Lee, M. A., Cameron, O. G., & Greden, J. F. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90078-2 · Cited by 58
Happonen, P., Voutilainen, S., Tuomainen, T., & Salonen, J. T. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000117 · Cited by 56
Yabuuchi, K., Kuroiwa, M., Shuto, T., Sotogaku, N., Snyder, G. L., Higashi, H., Tanaka, M., Greengard, P., & Nishi, A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.047 · Cited by 54
Luciano, M., Kirk, K. M., Heath, A. C., & Martin, N. G. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01223.x · Cited by 52
Hohoff, C., McDonald, J. M., Baune, B. T., Cook, E. H., Deckert, J., & de Wit, H. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30228 · Cited by 50
Genetics of coffee consumption and its stability
Laitala, V. S., Kaprio, J. A., & Silventoinen, K. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02375.x · Cited by 49
Yamada, K., Hattori, E., Shimizu, M., Sugaya, A., Shibuya, H., & Yoshikawa, T. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170033 · Cited by 48
The Cardiovascular Effects of Caffeine
Robertson, D., & Curatolo, P. W. (1984) · Springer eBooks · doi:10.1007/978-3-642-69823-1_5 · Cited by 42
Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study
Facheris, M., Schneider, N. K., Lesnick, T. G., de Andrade, M., Cunningham, J. M., Rocca, W. A., & Maraganore, D. M. (2008) · Movement Disorders · doi:10.1002/mds.22247 · Cited by 41
Hemodynamic Mechanisms Underlying the Incomplete Tolerance to Caffeine's Pressor Effects
Farag, N. H., Vincent, A. S., McKey, B. S., Whitsett, T. L., & Lovallo, W. R. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.093 · Cited by 41 · cited 1×
“For example, while the pressor effects of caffeine attenuate rapidly in most consumers upon repeated intake, tolerance remains incomplete in certain subjects (Farag et al. 2005; Lovallo et al. 2004).”
“No Thanks, It Keeps Me Awake”: The Genetics of Coffee-Attributed Sleep Disturbance
Luciano, M., Zhu, G., Kirk, K. M., Gordon, S. D., Heath, A. C., Montgomery, G. W., & Martin, N. G. (2007) · SLEEP · doi:10.1093/sleep/30.10.1378 · Cited by 40
A Genetic Analysis of Coffee Consumption in a Sample of Dutch Twins
Vink, J. M., Staphorsius, A. S., & Boomsma, D. I. (2009) · Twin Research and Human Genetics · doi:10.1375/twin.12.2.127 · Cited by 37
Bchir, F., Dogui, M., Ben Fradj, R., Arnaud, M. J., & Saguem, S. (2006) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2006.01.006 · Cited by 35
Caffeine increases its own metabolism through cytochrome P4501A induction in rats
Berthou, F., Goasduff, T., Dréano, Y., & Menez, J. F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00304-o · Cited by 32
Reduced appetite for caffeine in adenosine A2A receptor knockout mice
Yacoubi, M. E., Ledent, C. A., Parmentier, M., Costentin, J., & Vaugeois, J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.022 · Cited by 21
Tan, E., Lu, Z. Y., Fook-Chong, S. M. C., Tan, E., Shen, H., Chua, E., Yih, Y., Teo, Y., & Zhao, Y. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30359 · Cited by 17
The genetics of coffee-attributed sleep disturbance.
Luciano, M. (2008) · Cited by 8
Cited by
Genetic determinants of the gut microbiome in UK twins
Goodrich, J. K., Davenport, E. R., Beaumont, M., Jackson, M. A., Knight, R., Ober, C., Spector, T. D., Bell, J. T., Clark, A. G., & Ley, R. E. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.017 · Cited by 1,048
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Functional Properties of Coffee and Coffee By-Products
Esquivel, P., & Jiménez, V. M. (2012) · Food Research International · doi:10.1016/j.foodres.2011.05.028 · Cited by 847
A Review of Caffeine’s Effects on Cognitive, Physical and Occupational Performance
McLellan, T. M., Caldwell, J. A., & Lieberman, H. R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.001 · Cited by 840
“Such individuals often are not egular consumers of caffeine (Yang et al., 2010) so their excesive sensitivity to the drug may reduce or eliminate its potential ositive effects on physical and cognitive function.”
BackgroundInternational society of sports nutrition position stand: caffeine and performance
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby, D., Stout, J., Graves, B. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-5 · Cited by 686
Metadata
- Authors
- Yang, A., Palmer, A. A., & de Wit, H.
- Venue
- Psychopharmacology
- Published
- 2010-06-09
- Volume
- 211
- Issue
- 3
- Pages
- 245-257
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2016099963
- Cited by
- 309
- References
- 112
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.